Analysis/NN
of/IN
Oct2-isoform/JJ
expression/NN
in/IN
lipopolysaccharide-stimulated/JJ
B/NN
lymphocytes/NNS
./.

Oct2-isoform/JJ
expression/NN
in/IN
splenic/JJ
B/NN
cells/NNS
stimulated/VBN
with/IN
lipopolysaccharide/NN
or/CC
lipopolysaccharide/NN
plus/CC
phorbol-di-butyrate/NN
was/VBD
analysed/VBN
by/IN
cDNA/NN
cloning/NN
./.
=====
The/DT
frequency/NN
of/IN
Oct2-positive/JJ
clones/NNS
was/VBD
1/15,000/CD
in/IN
both/DT
libraries/NNS
./.
=====
Two/CD
new/JJ
isoforms/NNS
were/VBD
found/VBN
that/WDT
generate/VBP
novel/JJ
amino-/NN
or/CC
carboxy-terminal/JJ
sequences/NNS
./.
=====
An/DT
isoform/NN
lacking/VBG
exon/NN
11/CD
destroyed/VBD
the/DT
carboxy-terminal/JJ
leucin-zipper/NN
region/NN
and/CC
introduced/VBD
a/DT
frame/NN
shift/NN
creating/VBG
a/DT
novel/JJ
,/,
proline-rich/JJ
carboxy/NN
terminus/NN
./.
=====
A/DT
new/JJ
exon/NN
containing/VBG
a/DT
highly/RB
basic/JJ
region/NN
(/(
4c/NN
)/)
was/VBD
characterized/VBN
,/,
between/IN
exons/NNS
4/CD
and/CC
5/CD
./.
=====
This/DT
exon/NN
was/VBD
inserted/VBN
between/IN
glutamine-rich/JJ
regions/NNS
2/CD
and/CC
3/CD
,/,
carboxy/JJ
terminal/NN
of/IN
a/DT
tentative/JJ
leucine-zipper/NN
structure/NN
./.
=====
In/IN
addition/NN
,/,
a/DT
new/JJ
combination/NN
isoform/NN
containing/VBG
Oct2a/NN
's/POS
amino/NN
terminal/JJ
insert/NN
(/(
exon/NN
7a/NN
)/)
and/CC
Oct2b/NN
's/POS
carboxy/NN
terminal/JJ
insert/NN
(/(
exon/NN
13/CD
)/)
was/VBD
found/VBN
that/WDT
created/VBD
a/DT
novel/JJ
large/JJ
isoform/NN
,/,
Oct2ab/NN
./.
=====
More/RBR
frequent/JJ
use/NN
of/IN
the/DT
classical/JJ
Oct2a/NN
and/CC
Oct2b/NN
isoforms/NNS
was/VBD
observed/VBN
in/IN
the/DT
lipopolysaccharide-stimulated/JJ
B/NN
cells/NNS
,/,
while/IN
a/DT
preference/NN
for/IN
the/DT
Oct2ab/NN
and/CC
Oct2ba/NN
isoforms/NNS
was/VBD
observed/VBN
in/IN
lipopolysaccharide/NN
plus/CC
phorbol-di-butyrate-treated/JJ
cells/NNS
./.